The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 11, 2025

Filed:

Nov. 01, 2024
Applicant:

Kura Oncology, Inc., San Diego, CA (US);

Inventors:

Roger Paul Bakale, Cardiff, CA (US);

Kenneth K. Liu, Fremont, CA (US);

Yun Shan, San Diego, CA (US);

Xiufeng Sun, Oceanside, CA (US);

Patricia Andres, Bend, OR (US);

Song Chen, Beijing, CN;

Yue Lu, Ningbo, CN;

Licheng Song, Beijing, CN;

Catalina Ferrer, Groningen, NL;

Ana Rita Neves, Frankfurt am Main, DE;

Assignee:

Kura Oncology, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 491/08 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 31/4748 (2006.01);
U.S. Cl.
CPC ...
C07D 491/08 (2013.01); A61K 9/2009 (2013.01); A61K 9/2013 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 9/282 (2013.01); A61K 9/2853 (2013.01); A61K 31/4748 (2013.01);
Abstract

The present disclosure relates to solid forms of Compound 1, or a pharmaceutically acceptable form thereof, a pharmaceutically acceptable salt of Compound 1, or pharmaceutically acceptable solvate thereof, pharmaceutical compositions comprising the same, methods of preparing the same, and methods of treating cancer dependent on a farnesylated protein, using the same.


Find Patent Forward Citations

Loading…